These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34802103)

  • 21. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
    Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
    Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Asymptomatic skeletal muscle metastases from non-small cell lung cancer].
    Raoufi M; Oukabli M; Biyi A; Elouazzani H; Rhorfi IA; Abid A
    Pan Afr Med J; 2015; 22():181. PubMed ID: 26918076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery.
    Deng HY; Zhou Q
    Ann Surg Oncol; 2020 Feb; 27(2):470-471. PubMed ID: 31620942
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: A Simple Method to Predict Risk Factors of Complications After Pneumonectomy.
    Li Z; He W; Wang C
    Ann Surg Oncol; 2022 Jan; 29(1):570-571. PubMed ID: 34379252
    [No Abstract]   [Full Text] [Related]  

  • 26. Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer†.
    Sun C; Anraku M; Karasaki T; Kuwano H; Nagayama K; Nitadori JI; Sato M; Nakajima J
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):414-420. PubMed ID: 30289481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflections: A Novel Concept to Decreasing the Technical Difficulty of Complex Pulmonary Segmentectomy.
    Zhu Y; Liu L
    Ann Surg Oncol; 2020 Aug; 27(8):3094-3095. PubMed ID: 32285280
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Significance of Skeletal Muscle Loss After Esophagectomy for Esophageal Cancer.
    Nakashima Y; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):499. PubMed ID: 31754911
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: Using Patient-Reported Outcomes to Compare Thoracoscopic Segmentectomy and Lobectomy.
    Dai W; Mu Y; Chang S; Wu Z; Che G
    Ann Surg Oncol; 2022 Jan; 29(1):557-558. PubMed ID: 34671885
    [No Abstract]   [Full Text] [Related]  

  • 30. [Skeletal muscle metastases from non small cell lung].
    Faure E; Le Pimpec-Barthes F; Dusser D; Riquet M
    Rev Mal Respir; 2002 Feb; 19(1):93-5. PubMed ID: 17546820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply to Deng et al.
    Sun C; Anraku M; Nakajima J
    Eur J Cardiothorac Surg; 2019 Aug; 56(2):420-424. PubMed ID: 30561589
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.
    Kimura M; Naito T; Kenmotsu H; Taira T; Wakuda K; Oyakawa T; Hisamatsu Y; Tokito T; Imai H; Akamatsu H; Ono A; Kaira K; Murakami H; Endo M; Mori K; Takahashi T; Yamamoto N
    Support Care Cancer; 2015 Jun; 23(6):1699-708. PubMed ID: 25430482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASO Author Reflections: PD-L2 Expression in Lung Squamous Cell Carcinoma-One of the Potential Important Prognostic Factors.
    Matsubara T; Takada K; Maehara Y
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):676-677. PubMed ID: 31385129
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC.
    Mallet R; Decazes P; Modzelewski R; Lequesne J; Vera P; Dubray B; Thureau S
    Sci Rep; 2021 May; 11(1):10628. PubMed ID: 34017035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
    Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival.
    Kucukarda A; Gokyer A; Gokmen I; Bekir Hacioglu M; Kostek O; Kurt N; Karabulut D; Tuncbilek N; Uzunoglu S; Erdogan B; Cicin I
    J BUON; 2021; 26(3):853-860. PubMed ID: 34268945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASO Author Reflections: Prognostic Impact of the Primary Tumor Resection for Lung Cancer Patients Diagnosed with Pleural Dissemination in the Perioperative Period-Importance of Biomarker-Based Treatment Decision Making.
    Shien K; Fujiwara T; Toyooka S
    Ann Surg Oncol; 2023 Oct; 30(11):6703-6704. PubMed ID: 37355523
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
    Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of a multimodal intervention on malnutrition in patients with lung cancer during primary anti-neoplastic treatment.
    Tobberup R; Carus A; Rasmussen HH; Falkmer UG; Jorgensen MG; Schmidt EB; Jensen NA; Mark EB; Delekta AM; Antoniussen CS; Bøgsted M; Holst M
    Clin Nutr; 2021 Feb; 40(2):525-533. PubMed ID: 32600857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASO Author Reflections: C-Reactive Protein/Albumin Ratio as a Prognostic Factor in Patients with Malignant Pleural Mesothelioma: What Does the Novel Index Represent?
    Takamori S; Takenoyama M
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):958-959. PubMed ID: 30353392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.